Skip to content
thestock.space

On 6 Nov 2026, Fortis Healthcare was priced at ₹766.90, or 55.7× trailing earnings, against an industry P/E of 47.7×, and the shares are 25% below their 52-week high. Sales and net profit grew 13% and 21% a year over 3 years, with ROCE of 12% and ROE of 10%. Debt is 0.29× equity, and its dividend yield is 0.1%. It is a mid-cap company with a market cap of ₹57,898 Cr, ranked 5th of 40 Medical Care Facilities companies by market cap; the shares fell 20% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Sep 2026.How we calculate this

past year
Open
₹804.80
Day high
₹816.35
Day low
₹762.60
Prev. close
₹819.80
Volume
20.5 L

Health check

2 good · 2 fair · 2 to check
  • ReturnsBehind

    −19.6% over a year, better than 0 of 7 peers.

  • Price tagPricier

    P/E 55.7 vs industry 47.7.

  • GrowthSteady

    Sales +13.3%, profit +20.9% a year over 3 years.

  • ProfitabilityAverage

    ROCE 11.9% vs peer median 11.4%.

  • Balance sheetSolid

    Debt 0.29× equity, interest covered 5.8×, Piotroski 8 of 9.

  • Red flagsNone found

    No warning signs in the headline numbers.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Medical Care Facilities

39 listed peers. Screen the industry

Mid cap

₹57,898 Cr, #5 of 40 in its industry by size.

Defensive

Beta 0.67 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Sep 2026: sales ₹9,910 Cr · profit ₹1,038 Cr
Market cap
₹57,898 Cr
Mid cap
P/E
55.7
Industry 47.7
Price to book
5.52
Peers 8.63
Dividend yield
0.13%
ROE
10.4%
Peers 12.8%
ROCE
11.9%
Peers 11.4%
Debt to equity
0.29
Debt ₹3,164 Cr
EPS (TTM)
₹13.76
Face value ₹10
OPM (TTM)
22.2%
Net margin 10.5%
Sales growth
+17.3%
Latest quarter vs a year ago
Profit growth
−3.0%
Latest quarter vs a year ago
Price to sales
5.84
EV/EBITDA 29.2

Strengths and risks

Strengths

  • Quarterly sales up 17.3% on a year ago.
  • Positive operating cash flow in each of the last 4 years.

No obvious red flags in the headline numbers.

Derived automatically from reported figures. Not a recommendation.

About Fortis Healthcare

Fortis Healthcare Limited operates as a healthcare delivery service provider in India. The company services in the areas of cardiac science, nephrology, diabetology/endocrinology, foetal medicine, infectious diseases, mental health and behavioral science, oncology, orthopedics, physiotherapy and rehabilitation, rheumatology, urology, nuclear medicine, critical care, emergency and trauma, general surgery, internal medicine, neurointerventional radiology,…

Headquarters
Gurugram
Employees
14,649
Sector
Healthcare
ISIN
INE061F01013
Website
fortishealthcare.com

Price range

52 weeks

₹704.95₹1,020.30

Today

₹762.60₹816.35
Avg volume (3M)
15.9 L
1-year return
minus 19.6%
From 52-week high
minus 24.8%

Analyst consensus

20 analysts
Strong buyMean target ₹1,061.30 plus 38.4%

Target range, with today’s price

Low ₹810.00High ₹1,180.00

Today’s price ₹766.90 is below the lowest analyst target.

Consensus from Yahoo Finance. Not a recommendation.

Peers · Medical Care Facilities

Compare with peersScreen the whole industry
Company
APOLLOHOSPApollo Hospitals Enterprise8,446.00plus 0.90%1,21,44154.011.4519.2%22.5%15.4%14.8%33.3%0.24%plus 7.2%
MAXHEALTHMax Healthcare Institute934.00plus 0.21%90,90966.18.0312.6%12.8%26.8%22.4%9.3%0.21%minus 18.1%
MANIPALHOSManipal Health Enterprises646.70minus 1.61%85,065133.69.059.8%9.2%17.8%––0.00%minus 3.0%
ASTERDMAster DM Quality Care713.15minus 0.89%62,09290.78.069.4%9.7%17.4%15.7%−3.0%0.42%plus 4.5%
FORTISFortis Healthcare766.90minus 6.45%57,89855.75.5211.9%10.4%22.2%13.3%20.9%0.13%minus 19.6%
NHNarayana Hrudayalaya1,903.00minus 0.65%38,65044.77.7311.4%19.1%18.5%20.5%9.9%0.24%plus 4.7%
MEDANTAGlobal Health1,387.60minus 0.15%37,26460.48.6315.0%15.2%22.1%17.2%19.5%0.04%plus 11.2%
KIMSKrishna Institute of Medical Sciences723.00minus 1.10%30,366138.512.878.1%11.0%19.8%21.3%−10.5%0.00%plus 2.0%
Median of 7 peers–−0.65%62,09266.18.6311.4%12.8%18.5%18.8%9.6%0.21%4.5%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrSep 25Dec 25Mar 26Jun 26Sep 26
2,3312,2652,3652,5452,735
1,7751,7591,8322,0082,112
556506532537623
23.9%22.3%22.5%21.1%22.8%
26.311.810.618.912.8
74.985.784.380.478.3
106120122122128
23.5−45.9−12.59.53
425266324363432
22.7%25.7%16.4%24.9%25.9%
322194266266312
4.262.573.523.534.14

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+13.3%
Profit CAGR 3Y
+20.9%
EPS CAGR 3Y
+20.9%
ROE
10.4%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
6,2136,8357,7249,048
–+10.0%+13.0%+17.1%
5,1275,5806,1466,984
1,0861,2551,5782,064
17.5%18.4%20.4%22.8%
65.43864.952.6
108108155283
316342386449
86.415.7−95.8−18.5
8148581,0071,366
22.2%24.8%19.6%22.1%
5895997741,042
–+1.7%+29.3%+34.6%
7.807.9310.2613.80

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
755755755755
6,4876,9088,1629,141
9261,1552,4753,473
4,2664,4712,3002,598
12,43413,28913,69215,966
5,1075,8296,3447,343
257561496456
49.22.93.23.5
366600506559
6,6556,2956,3427,605
12,43413,28913,69215,966

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
8221,1001,4241,601
−374−886−779−1,538
−471−86.5−714164
−22.7127−69.3227
−447−942−847−945
375158577656
−16−86−109−77.7

Shareholding pattern

Source: NSE filings
31.2%
promoters
  • Promoters31.17%
  • Public68.83%
  • As of 30 Sep 2026
QuarterSplitPromotersPublicPromoter change
30 Sep 202631.17%68.83%0.00
30 Jun 202631.17%68.83%0.00
31 Mar 202631.17%68.83%0.00
31 Dec 202531.17%68.83%0.00
30 Sep 202531.17%68.83%–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you